Balancing Efficacy and Risk in ADHD PharmacotherapyByHelene Alphonso, DOJune 1st 2026Weighing the risks and benefits of stimulants to treat ADHD.
Stimulant Prescribing in ADHD: Reassessing Risk-Benefit EvidenceByHelene Alphonso, DOMay 26th 2026APA session probes ADHD stimulant prescribing, contrasts population studies with RCTs, and explores education and brain effects.